Skip to Content

Scopolamine Transdermal System

Last Updated: November 20, 2019
Status: Resolved

Reason for the Shortage
    • Baxter has scopolamine patches available.
    • GlaxoSmithKline states the shortage was due to increased demand.
    • Perrigo has scopolamine patches available.
Available Products
    • Transderm Scop transdermal system, Baxter, 1.5 mg (1 mg/3 days), 10 count, NDC 10019-0553-03
    • Transderm Scop transdermal system, Baxter, 1.5 mg (1 mg/3 days), 24 count, NDC 10019-0553-04
    • Transderm Scop transdermal system, GlaxoSmithKline, 1.5 mg (1 mg/3 days), 4 count, NDC 66758-0208-54
    • Scopolamine transdermal system, Perrigo, 1.3 mg (1 mg/3 days), 4 count, NDC 45802-0580-84
    • Scopolamine transdermal system, Perrigo, 1.3 mg (1 mg/3 days), 10 count, NDC 45802-0580-46
    • Scopolamine transdermal system, Perrigo, 1.3 mg (1 mg/3 days), 24 count, NDC 45802-0580-62

Updated

Updated November 20, 2019 by Rachael Freeman, PharmD, BCPS. Created July 17, 2018 by Leslie Jensen, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.